Tommy B Andersson Selected Research

Midazolam (Versed)

8/2022	Correlations between 4β-hydroxycholesterol and hepatic and intestinal CYP3A4: protein expression, microsomal ex vivo activity, and in vivo activity in patients with a wide body weight range.
1/2022	Short- and long-term effects of body weight loss following calorie restriction and gastric bypass on CYP3A-activity - a non-randomized three-armed controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tommy B Andersson Research Topics

Disease

6	Body Weight (Weight, Body) 08/2022 - 01/2018
5	Breast Neoplasms (Breast Cancer) 01/2021 - 04/2010
5	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 11/2002
4	Obesity 01/2022 - 01/2020
3	Weight Loss (Weight Reduction) 01/2022 - 01/2018
3	Chemical and Drug Induced Liver Injury 12/2016 - 04/2008
2	Overweight 01/2022 - 01/2022
2	Liver Diseases (Liver Disease) 08/2017 - 11/2016
1	Inflammation (Inflammations) 01/2022
1	Heart Failure 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Non-alcoholic Fatty Liver Disease 12/2019
1	Type 2 Diabetes Mellitus (MODY) 11/2017
1	Communicable Diseases (Infectious Diseases) 01/2015
1	Drug-Related Side Effects and Adverse Reactions 09/2008

Drug/Important Bio-Agent (IBA)

14	Pharmaceutical PreparationsIBA 01/2022 - 05/2011
7	Proteins (Proteins, Gene)FDA Link 08/2022 - 04/2010
5	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2022 - 03/2014
4	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2021 - 04/2010
3	Cytochrome P-450 CYP3AIBA 08/2022 - 12/2012
3	EnzymesIBA 01/2021 - 11/2002
2	Midazolam (Versed)FDA LinkGeneric 08/2022 - 01/2022
2	Cytochrome P-450 CYP2C9IBA 01/2022 - 12/2012
2	ATP-Binding Cassette Sub-Family B Member 4IBA 12/2012 - 04/2010
2	ximelagatran (Exanta)IBA 09/2008 - 04/2008
1	Losartan (Cozaar)FDA LinkGeneric 01/2022
1	5-hydroxymethylomeprazoleIBA 01/2022
1	losartan carboxylic acidIBA 01/2022
1	Caffeine (No Doz)FDA LinkGeneric 01/2022
1	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 01/2022
1	Cytochrome P-450 CYP2C19IBA 01/2022
1	1,7-dimethylxanthine (paraxanthine)IBA 01/2022
1	Omeprazole (Prilosec)FDA LinkGeneric 01/2022
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2021
1	verinuradIBA 01/2021
1	Uric Acid (Urate)IBA 01/2021
1	Organic Anion TransportersIBA 01/2021
1	Apolipoproteins B (ApoB)IBA 12/2019
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 11/2017
1	Multidrug Resistance-Associated ProteinsIBA 03/2014
1	Multidrug Resistance-Associated Protein 2IBA 05/2011
1	Sucrose (Saccharose)IBA 04/2010
1	Membrane Proteins (Integral Membrane Proteins)IBA 04/2010
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 04/2010
1	ChemokinesIBA 09/2008
1	CytokinesIBA 09/2008
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 07/2008
1	Antiparasitic Agents (Antiparasitics)IBA 11/2002
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 11/2002

Therapy/Procedure

4	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2022 - 01/2018
1	Bioreactors (Bioreactor) 12/2012